Cargando…
MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity
Localized prostate cancer develops very slowly in most men, with the androgen receptor (AR) and MYC transcription factors amongst the most well-characterized drivers of prostate tumorigenesis. Canonically, MYC up-regulation in luminal prostate cancer cells functions to oppose the terminally differen...
Autores principales: | Whitlock, Nichelle C., Trostel, Shana Y., Wilkinson, Scott, Terrigino, Nicholas T., Hennigan, S. Thomas, Lake, Ross, Carrabba, Nicole V., Atway, Rayann, Walton, Elizabeth D., Gryder, Berkley E., Capaldo, Brian J., Ye, Huihui, Sowalsky, Adam G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441006/ https://www.ncbi.nlm.nih.gov/pubmed/32681068 http://dx.doi.org/10.1038/s41388-020-01389-7 |
Ejemplares similares
-
Low Abundance of Circulating Tumor DNA in Localized Prostate Cancer
por: Hennigan, S. Thomas, et al.
Publicado: (2019) -
A case report of multiple primary prostate tumors with differential drug sensitivity
por: Wilkinson, Scott, et al.
Publicado: (2020) -
Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A
por: Whitlock, Nichelle C., et al.
Publicado: (2022) -
AR-V7 biomarker testing for primary prostate cancer: The ongoing challenge of analytical validation and clinical qualification
por: Sowalsky, Adam G., et al.
Publicado: (2020) -
MEIS-mediated suppression of human prostate cancer growth and metastasis through HOXB13-dependent regulation of proteoglycans
por: VanOpstall, Calvin, et al.
Publicado: (2020)